Effect of cyclosporin A on immunoglobulin class in patients receiving blood transfusions

B K Weber, M C Jones, G Hillis, G R Catto, A M MacLeod

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

IgG antibodies detected by flow cytometry in sera from potential renal transplant recipients are associated with an increased number of rejection episodes and impaired graft function. Furthermore, cytotoxic antibodies may develop if pre-transplant blood transfusions are given to such patients. We have investigated the effect of cyclosporin A on the development of IgM and IgG antibodies detected by flow cytometry after blood transfusions in 16 previously untransfused dialysis patients. Eight (group 1) received three to five third-party blood transfusions at two weekly intervals and the remaining eight (group 2) received transfusions with concomitant cyclosporin A therapy (10 mg/kg/day). Sera obtained after each transfusion were tested using flow cytometry against lymphocytes from six normal donors. In all 462 serum/cell combinations were tested. Sera from six out of eight patients in group 1 showed IgG antibody activity following blood transfusions and none developed IgM antibodies alone. In contrast IgG antibody activity was detected in one serum sample from only one of the eight patients in group 2 (P less than 0.02); a further three patients developed IgM but not IgG antibody activity during the transfusion protocol. IgG antibodies were found in 25/228 serum/cell combinations in group 1 but in 1/234 in group 2 (P less than 0.001). The patient in group 2 who developed IgG antibodies in one serum/cell combination was known to have red cell autoantibodies. This IgG activity was removed by red cell absorption, suggesting that the autoreactive red cell antibody cross-reacted with lymphocytes. Cytotoxic antibodies were detected in two serum/cell combinations in group 1 alone.(ABSTRACT TRUNCATED AT 250 WORDS)
Original languageEnglish
Pages (from-to)328-32
Number of pages5
JournalKidney International
Volume39
Issue number2
Publication statusPublished - 1 Feb 1991

Fingerprint

Immunoglobulin Isotypes
Blood Transfusion
Cyclosporine
Antibodies
Immunoglobulin G
Serum
Immunoglobulin M
Flow Cytometry
Lymphocytes
Transplants
Autoantibodies
Dialysis
Tissue Donors
Kidney

Keywords

  • Antibody Formation
  • Blood Transfusion
  • Cyclosporins
  • Female
  • Flow Cytometry
  • Graft Rejection
  • Humans
  • Immunoglobulin G
  • Immunoglobulin M
  • Isoantibodies
  • Kidney Transplantation
  • Male

Cite this

Weber, B. K., Jones, M. C., Hillis, G., Catto, G. R., & MacLeod, A. M. (1991). Effect of cyclosporin A on immunoglobulin class in patients receiving blood transfusions. Kidney International, 39(2), 328-32.

Effect of cyclosporin A on immunoglobulin class in patients receiving blood transfusions. / Weber, B K; Jones, M C; Hillis, G; Catto, G R; MacLeod, A M.

In: Kidney International, Vol. 39, No. 2, 01.02.1991, p. 328-32.

Research output: Contribution to journalArticle

Weber, BK, Jones, MC, Hillis, G, Catto, GR & MacLeod, AM 1991, 'Effect of cyclosporin A on immunoglobulin class in patients receiving blood transfusions' Kidney International, vol. 39, no. 2, pp. 328-32.
Weber, B K ; Jones, M C ; Hillis, G ; Catto, G R ; MacLeod, A M. / Effect of cyclosporin A on immunoglobulin class in patients receiving blood transfusions. In: Kidney International. 1991 ; Vol. 39, No. 2. pp. 328-32.
@article{b6f93fc40e5a434389426cb70d5f3eef,
title = "Effect of cyclosporin A on immunoglobulin class in patients receiving blood transfusions",
abstract = "IgG antibodies detected by flow cytometry in sera from potential renal transplant recipients are associated with an increased number of rejection episodes and impaired graft function. Furthermore, cytotoxic antibodies may develop if pre-transplant blood transfusions are given to such patients. We have investigated the effect of cyclosporin A on the development of IgM and IgG antibodies detected by flow cytometry after blood transfusions in 16 previously untransfused dialysis patients. Eight (group 1) received three to five third-party blood transfusions at two weekly intervals and the remaining eight (group 2) received transfusions with concomitant cyclosporin A therapy (10 mg/kg/day). Sera obtained after each transfusion were tested using flow cytometry against lymphocytes from six normal donors. In all 462 serum/cell combinations were tested. Sera from six out of eight patients in group 1 showed IgG antibody activity following blood transfusions and none developed IgM antibodies alone. In contrast IgG antibody activity was detected in one serum sample from only one of the eight patients in group 2 (P less than 0.02); a further three patients developed IgM but not IgG antibody activity during the transfusion protocol. IgG antibodies were found in 25/228 serum/cell combinations in group 1 but in 1/234 in group 2 (P less than 0.001). The patient in group 2 who developed IgG antibodies in one serum/cell combination was known to have red cell autoantibodies. This IgG activity was removed by red cell absorption, suggesting that the autoreactive red cell antibody cross-reacted with lymphocytes. Cytotoxic antibodies were detected in two serum/cell combinations in group 1 alone.(ABSTRACT TRUNCATED AT 250 WORDS)",
keywords = "Antibody Formation, Blood Transfusion, Cyclosporins, Female, Flow Cytometry, Graft Rejection, Humans, Immunoglobulin G, Immunoglobulin M, Isoantibodies, Kidney Transplantation, Male",
author = "Weber, {B K} and Jones, {M C} and G Hillis and Catto, {G R} and MacLeod, {A M}",
year = "1991",
month = "2",
day = "1",
language = "English",
volume = "39",
pages = "328--32",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Effect of cyclosporin A on immunoglobulin class in patients receiving blood transfusions

AU - Weber, B K

AU - Jones, M C

AU - Hillis, G

AU - Catto, G R

AU - MacLeod, A M

PY - 1991/2/1

Y1 - 1991/2/1

N2 - IgG antibodies detected by flow cytometry in sera from potential renal transplant recipients are associated with an increased number of rejection episodes and impaired graft function. Furthermore, cytotoxic antibodies may develop if pre-transplant blood transfusions are given to such patients. We have investigated the effect of cyclosporin A on the development of IgM and IgG antibodies detected by flow cytometry after blood transfusions in 16 previously untransfused dialysis patients. Eight (group 1) received three to five third-party blood transfusions at two weekly intervals and the remaining eight (group 2) received transfusions with concomitant cyclosporin A therapy (10 mg/kg/day). Sera obtained after each transfusion were tested using flow cytometry against lymphocytes from six normal donors. In all 462 serum/cell combinations were tested. Sera from six out of eight patients in group 1 showed IgG antibody activity following blood transfusions and none developed IgM antibodies alone. In contrast IgG antibody activity was detected in one serum sample from only one of the eight patients in group 2 (P less than 0.02); a further three patients developed IgM but not IgG antibody activity during the transfusion protocol. IgG antibodies were found in 25/228 serum/cell combinations in group 1 but in 1/234 in group 2 (P less than 0.001). The patient in group 2 who developed IgG antibodies in one serum/cell combination was known to have red cell autoantibodies. This IgG activity was removed by red cell absorption, suggesting that the autoreactive red cell antibody cross-reacted with lymphocytes. Cytotoxic antibodies were detected in two serum/cell combinations in group 1 alone.(ABSTRACT TRUNCATED AT 250 WORDS)

AB - IgG antibodies detected by flow cytometry in sera from potential renal transplant recipients are associated with an increased number of rejection episodes and impaired graft function. Furthermore, cytotoxic antibodies may develop if pre-transplant blood transfusions are given to such patients. We have investigated the effect of cyclosporin A on the development of IgM and IgG antibodies detected by flow cytometry after blood transfusions in 16 previously untransfused dialysis patients. Eight (group 1) received three to five third-party blood transfusions at two weekly intervals and the remaining eight (group 2) received transfusions with concomitant cyclosporin A therapy (10 mg/kg/day). Sera obtained after each transfusion were tested using flow cytometry against lymphocytes from six normal donors. In all 462 serum/cell combinations were tested. Sera from six out of eight patients in group 1 showed IgG antibody activity following blood transfusions and none developed IgM antibodies alone. In contrast IgG antibody activity was detected in one serum sample from only one of the eight patients in group 2 (P less than 0.02); a further three patients developed IgM but not IgG antibody activity during the transfusion protocol. IgG antibodies were found in 25/228 serum/cell combinations in group 1 but in 1/234 in group 2 (P less than 0.001). The patient in group 2 who developed IgG antibodies in one serum/cell combination was known to have red cell autoantibodies. This IgG activity was removed by red cell absorption, suggesting that the autoreactive red cell antibody cross-reacted with lymphocytes. Cytotoxic antibodies were detected in two serum/cell combinations in group 1 alone.(ABSTRACT TRUNCATED AT 250 WORDS)

KW - Antibody Formation

KW - Blood Transfusion

KW - Cyclosporins

KW - Female

KW - Flow Cytometry

KW - Graft Rejection

KW - Humans

KW - Immunoglobulin G

KW - Immunoglobulin M

KW - Isoantibodies

KW - Kidney Transplantation

KW - Male

M3 - Article

VL - 39

SP - 328

EP - 332

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 2

ER -